Shmuel Ben Zvi
Directeur/Membre du Conseil chez BANK LEUMI LE-ISRAEL B.M.
Fortune : - $ au 30/04/2024
Postes actifs de Shmuel Ben Zvi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Directeur/Membre du Conseil | 29/07/2015 | - |
| Independent Dir/Board Member | 29/07/2015 | - | |
| PROTALIX BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/06/2022 | - |
| Independent Dir/Board Member | 30/06/2022 | - | |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - | - |
Historique de carrière de Shmuel Ben Zvi
Anciens postes connus de Shmuel Ben Zvi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NOTABLE LABS, LTD. | Directeur/Membre du Conseil | 01/09/2018 | 16/10/2023 |
| Independent Dir/Board Member | 01/09/2018 | 16/10/2023 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2004 | 01/12/2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01/01/2000 | 01/01/2004 |
| SOL-GEL TECHNOLOGIES LTD. | Directeur/Membre du Conseil | 01/01/2018 | - |
| Independent Dir/Board Member | 01/01/2018 | - |
Formation de Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Statistiques
Internationale
| Israël | 8 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 3 |
Sectorielle
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
- Bourse
- Insiders
- Shmuel Ben Zvi
- Expérience
